Fundación MEDINA is a Non Profit Research center established in 2008 through a public-private alliance between the Regional government of andalusia, the pharmaceutical company Merck Sharp & Dohme Spain S.A. (MSD), and the University of Granada.
The team working with MSD’s microbial collection has a collective experience with and unbroken historical ties to successfully marketed drugs (MEFOXIN, PRIMAXIN, MEVACOR and CANCIDAS) and to some of the most important natural products discoveries of recent decades (platensimycin and platencin, moriniafungin, enfumafungin, parnafungins, lucensimycin, philipimycin, and kibdelomycin among others).
Fundación MEDINA has capitalized on its experience, personnel and equipment to position itself as a new Centre of Excellence for research and development in drug discovery. Currently, its permanent scientists have been attracted from the pharmaceutical, biotech and academic sectors, and they operate as part of a multidisciplinary team with skills ranging from molecular and cell biology, industrial and medical microbiology, informatics and automation, compound management and analytical and natural products chemistry.
This experience is enriched by the opportunities offered by the Health Sciences Technological Park in Granada to establish collaborations with biotech companies, academic and clinical research groups from the University and theAndalusian Health Institute, a unique research network that favors the possibilities of translational research into the clinic.
MEDINA currently has active research collaborations with international research groups in the academic and the industrial sectors.